IMS
ESPR

Index Management Solutions’s Esperion Therapeutics ESPR Stock Holding History

Index Management Solutions’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$1K Buy
58
+15
+35% +$941 ﹤0.01% 706
2015
Q2 		$4K Buy
+43
New +$4.21K ﹤0.01% 710

Other funds holding ESPR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Index Management Solutions's ESPR Position: Q3 2015 in Review

Index Management Solutions increased its Esperion Therapeutics (ESPR) stake by 35% in Q3 2015, buying an estimated $941 and bringing the position to 58 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #706.

Index Management Solutions first reported a position in ESPR in Q2 2015 and has held it in 2 quarters since. The position peaked at $4K in Q2 2015. 121 funds tracked by Wall St. Rank hold ESPR as of Q3 2015.

  • Index Management Solutions held 58 shares of Esperion Therapeutics worth $1K as of Q3 2015.
  • Index Management Solutions bought 15 Esperion Therapeutics shares in Q3 2015, an estimated $941.
  • Esperion Therapeutics made up ﹤0.01% of Index Management Solutions's portfolio in Q3 2015, its #706 holding.
  • Index Management Solutions first reported a position in Esperion Therapeutics in Q2 2015 and has held it in 2 quarters since.
  • Index Management Solutions's Esperion Therapeutics position peaked at $4K in Q2 2015.
  • 121 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q3 2015.

Based on Index Management Solutions's 13F filing for Q3 2015, filed 13 Nov 2015.